Kalaris Therapeutics, Inc. ($KLRS)
Filing Information
| Accession Number | 0001193125-26-119707 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
62,715
Total Value
$12,868.80
P&L
+inf% (+$373,920.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Common Stock | โ | Mar 20, 2026 | Sale | 1,915 | $6.72 | $12,868.80 | 0 | Direct | โ | View Details | |
Chief Accounting Officer | Stock Option (Right to Buy) | Derivative | Mar 19, 2026 | Grant/Award | 60,800 | $0.00 | $0.00 | 60,800 | Direct | โ | View Details |